Gilead Sciences, Inc.
GLP-1R MODULATING COMPOUNDS
Last updated:
Abstract:
The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition in a human.
Status:
Application
Type:
Utility
Filling date:
18 Nov 2021
Issue date:
9 Jun 2022